Wilmington Savings Fund Society FSB Buys New Shares in HCA Healthcare, Inc. (NYSE:HCA)

Wilmington Savings Fund Society FSB purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,692 shares of the company's stock, valued at approximately $688,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. FMR LLC boosted its stake in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company's stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in HCA Healthcare during the second quarter worth $131,527,000. Darsana Capital Partners LP lifted its stake in HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company's stock valued at $369,472,000 after acquiring an additional 400,000 shares in the last quarter. Meritage Group LP purchased a new stake in shares of HCA Healthcare in the third quarter valued at about $150,548,000. Finally, Holocene Advisors LP grew its position in HCA Healthcare by 210.6% in the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company's stock worth $124,691,000 after purchasing an additional 208,015 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the business's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company's stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analyst Ratings Changes

HCA has been the topic of a number of research analyst reports. Wolfe Research raised shares of HCA Healthcare to a "strong-buy" rating in a report on Thursday, August 29th. Wells Fargo & Company downgraded HCA Healthcare from an "equal weight" rating to an "underweight" rating and cut their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Cantor Fitzgerald reissued an "overweight" rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Oppenheimer boosted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an "outperform" rating in a report on Monday, October 28th. Finally, TD Cowen reduced their price target on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating for the company in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $387.13.

HCA Healthcare Stock Down 1.4 %

Shares of HCA traded down $4.33 during mid-day trading on Monday, reaching $309.60. The company had a trading volume of 1,744,862 shares, compared to its average volume of 1,206,436. The firm has a 50-day moving average price of $355.34 and a 200 day moving average price of $358.75. The company has a market capitalization of $78.42 billion, a price-to-earnings ratio of 13.90, a price-to-earnings-growth ratio of 1.21 and a beta of 1.63. HCA Healthcare, Inc. has a 52 week low of $263.22 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. HCA Healthcare's dividend payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.